Published in J Clin Endocrinol Metab on September 05, 2013
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol (2014) 0.88
Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab (2015) 0.86
Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab (2016) 0.81
Maternal control of early embryogenesis in mammals. Reprod Fertil Dev (2015) 0.81
Optimal management of subfertility in polycystic ovary syndrome. Int J Womens Health (2014) 0.80
Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome. J Assist Reprod Genet (2015) 0.77
Polycystic ovary syndrome: what's in a name? J Clin Endocrinol Metab (2014) 0.77
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) (2016) 0.76
Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS? J Obstet Gynaecol India (2016) 0.75
Comment on trends in onomastics-the case of PCOS by Kalra et al. Indian J Endocrinol Metab (2014) 0.75
The Relationship between Adiposity and Insulin Sensitivity in African Women Living with the Polycystic Ovarian Syndrome: A Clamp Study. Int J Endocrinol (2016) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril (2004) 12.87
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 12.27
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod (2011) 2.71
Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics (2006) 2.31
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet (2012) 2.02
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2012) 1.76
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod (2013) 1.55
A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab (2008) 1.53
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update (2009) 1.52
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab (2012) 1.44
Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod (2011) 1.29
The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab (2010) 1.27
The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab (2007) 1.26
IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol (2009) 1.07
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 1.02
Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.01
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2009) 0.98
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod (2008) 0.96
Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol (2010) 0.91
[Stein-Leventhal syndrome; 4 case reports]. C R Soc Fr Gyncol (1958) 0.78
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet (2007) 3.36
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab (2003) 2.26
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod (2007) 2.11
The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev (2006) 1.75
Primary ovarian insufficiency. Lancet (2010) 1.67
Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab (2004) 1.61
The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci (2008) 1.50
Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol (2004) 1.46
Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med (2008) 1.44
Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome. Hum Reprod (2013) 1.40
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab (2008) 1.39
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab (2004) 1.37
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod (2004) 1.32
A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril (2002) 1.27
Balancing the strengths of systematic and narrative reviews. Hum Reprod Update (2004) 1.24
New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv (2002) 1.21
A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab (2007) 1.10
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
Tackling burden in ART: an integrated approach for medical staff. Hum Reprod (2012) 1.07
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril (2003) 1.06
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril (2002) 1.02
High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod (2003) 1.01
Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod (2009) 1.01
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update (2003) 0.96
Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril (2011) 0.95
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online (2011) 0.95
Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril (2009) 0.94
Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril (2002) 0.93
IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction. Reprod Biomed Online (2003) 0.93
Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab (2010) 0.92
Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. J Clin Endocrinol Metab (2011) 0.92
Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril (2002) 0.91
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril (2005) 0.89
The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril (2011) 0.89
Human studies on genetics of the age at natural menopause: a systematic review. Hum Reprod Update (2010) 0.89
Ovulation induction in normogonadotropic anovulation (PCOS). Best Pract Res Clin Endocrinol Metab (2006) 0.88
Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment. J Clin Endocrinol Metab (2011) 0.87
Contemporary pharmacological manipulation in assisted reproduction. Drugs (2004) 0.87
Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril (2007) 0.86
Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model. Fertil Steril (2011) 0.86
Copy number variants on the X chromosome in women with primary ovarian insufficiency. Fertil Steril (2011) 0.84
Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Hum Reprod (2005) 0.84
Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype. J Clin Endocrinol Metab (2013) 0.84
Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk. Menopause (2010) 0.84
Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI). Fertil Steril (2011) 0.84
Preimplantation genetic screening: the end of an affair? Hum Reprod (2008) 0.83
Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment. Eur J Endocrinol (2005) 0.83
Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference? J Clin Endocrinol Metab (2010) 0.83
Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol (2011) 0.83
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertil Steril (2003) 0.83
Preimplantation aneuploidy screening: a research tool for now. Lancet (2007) 0.83
Cell lineage specific distribution of H3K27 trimethylation accumulation in an in vitro model for human implantation. PLoS One (2012) 0.82
Lipid profile of women with premature ovarian failure. Menopause (2008) 0.81
Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online (2003) 0.81
Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Reprod Sci (2007) 0.80
FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur J Endocrinol (2002) 0.80
Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. Trends Endocrinol Metab (2005) 0.80
Cost-effectiveness of hysteroscopy screening for infertile women. Reprod Biomed Online (2013) 0.80
Predictors of recovery of ovarian function during weight gain in anorexia nervosa. Fertil Steril (2007) 0.79
High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. Fertil Steril (2012) 0.79
What role of estrogens in ovarian stimulation. Maturitas (2006) 0.79
The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol (2006) 0.77
Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5. J Clin Endocrinol Metab (2011) 0.76
Effect of B vitamins and genetics on success of in-vitro fertilisation. Lancet (2006) 0.76
Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome. Reprod Biomed Online (2005) 0.76
Is bacterial vaginosis associated with a pro-inflammatory cytokine profile in endometrial secretions of women undergoing IVF? Reprod Biomed Online (2010) 0.76
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive. Eur J Contracept Reprod Health Care (2013) 0.76
Similar phenotype characteristics comparing familial and sporadic premature ovarian failure. Menopause (2010) 0.75
Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women. Eur J Endocrinol (2005) 0.75
Important steps towards materializing the dream of developing an artificial ovary. Reprod Biomed Online (2016) 0.75
Gonadotropin therapy for the treatment of anovulation and for ovarian hyperstimulation for IVF. Mol Cell Endocrinol (2002) 0.75
Meet our new editor. Reprod Biomed Online (2015) 0.75
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome. Fertil Steril (2006) 0.75
Honouring the past and shaping the future. Reprod Biomed Online (2016) 0.75
Preimplantation genetic screening - what a wonderful world it would be! Reprod Biomed Online (2016) 0.75
[Wide support for oocyte donation and banking in the Netherlands]. Ned Tijdschr Geneeskd (2012) 0.75
What makes RBM Online special? The Chief Editor's point of view. Reprod Biomed Online (2016) 0.75
Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome. J Clin Endocrinol Metab (2004) 0.75